Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer

Fox transcription factors play a critical role in the regulation of a variety of biological processes. While FoxM1 behaves like the oncogenic transcription factor, FoxO3a is known as a tumor suppressor by inhibiting FoxM1. This study aimed to investigate the clinicopathological significance of FoxM1...

Full description

Bibliographic Details
Main Authors: Ahn, Hyein, Sim, Jongmin, Abdul, Rehman, Chung, Min Sung, Paik, Seung Sam, Oh, Young-Ha, Park, Chan Kum, Jang, Kiseok
Format: Online
Language:English
Published: The Korean Academy of Medical Sciences 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366959/
id pubmed-4366959
recordtype oai_dc
spelling pubmed-43669592015-04-01 Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Ahn, Hyein Sim, Jongmin Abdul, Rehman Chung, Min Sung Paik, Seung Sam Oh, Young-Ha Park, Chan Kum Jang, Kiseok Original Article Fox transcription factors play a critical role in the regulation of a variety of biological processes. While FoxM1 behaves like the oncogenic transcription factor, FoxO3a is known as a tumor suppressor by inhibiting FoxM1. This study aimed to investigate the clinicopathological significance of FoxM1 and FoxO3a expression in breast cancer. Expression of FoxM1 and FoxO3a were analyzed by immunohistochemical staining on tissue microarray sections from 236 breast cancer patients, and correlated with various clinicopathological characteristics. Overexpression of FoxM1 correlated with adverse clinicopathological features, such as larger tumor size, lymph node metastasis, advanced tumor stage, and lymphovascular invasion. The Kaplan-Meier survival curves revealed no prognostic significance of FoxM1 expression. However, in subgroup analyses with patients of estrogen receptor (ER) positive breast cancers, FoxM1 overexpression associated with poor disease free and overall survival. No association was found between FoxO3a and FoxM1 expression. Regarding clinicopathological variables, the only association between histologic grade and FoxO3a was observed. In conclusion, FoxM1 overexpression was significantly associated with aggressive phenotypes and poor prognosis of ER-positive breast cancer. These findings suggest the possible role of FoxM1 as a prognostic biomarker and putative target of anti-cancer therapy. The Korean Academy of Medical Sciences 2015-04 2015-03-19 /pmc/articles/PMC4366959/ /pubmed/25829806 http://dx.doi.org/10.3346/jkms.2015.30.4.390 Text en © 2015 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ahn, Hyein
Sim, Jongmin
Abdul, Rehman
Chung, Min Sung
Paik, Seung Sam
Oh, Young-Ha
Park, Chan Kum
Jang, Kiseok
spellingShingle Ahn, Hyein
Sim, Jongmin
Abdul, Rehman
Chung, Min Sung
Paik, Seung Sam
Oh, Young-Ha
Park, Chan Kum
Jang, Kiseok
Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
author_facet Ahn, Hyein
Sim, Jongmin
Abdul, Rehman
Chung, Min Sung
Paik, Seung Sam
Oh, Young-Ha
Park, Chan Kum
Jang, Kiseok
author_sort Ahn, Hyein
title Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
title_short Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
title_full Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
title_fullStr Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
title_full_unstemmed Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
title_sort increased expression of forkhead box m1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer
description Fox transcription factors play a critical role in the regulation of a variety of biological processes. While FoxM1 behaves like the oncogenic transcription factor, FoxO3a is known as a tumor suppressor by inhibiting FoxM1. This study aimed to investigate the clinicopathological significance of FoxM1 and FoxO3a expression in breast cancer. Expression of FoxM1 and FoxO3a were analyzed by immunohistochemical staining on tissue microarray sections from 236 breast cancer patients, and correlated with various clinicopathological characteristics. Overexpression of FoxM1 correlated with adverse clinicopathological features, such as larger tumor size, lymph node metastasis, advanced tumor stage, and lymphovascular invasion. The Kaplan-Meier survival curves revealed no prognostic significance of FoxM1 expression. However, in subgroup analyses with patients of estrogen receptor (ER) positive breast cancers, FoxM1 overexpression associated with poor disease free and overall survival. No association was found between FoxO3a and FoxM1 expression. Regarding clinicopathological variables, the only association between histologic grade and FoxO3a was observed. In conclusion, FoxM1 overexpression was significantly associated with aggressive phenotypes and poor prognosis of ER-positive breast cancer. These findings suggest the possible role of FoxM1 as a prognostic biomarker and putative target of anti-cancer therapy.
publisher The Korean Academy of Medical Sciences
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366959/
_version_ 1613201256367521792